Pasar al contenido principal

EL RECABLEADO DEL INTERACTOMA COMO UNA NUEVA VIA PARA EL DESARROLLO DE ANTIMICROBIANOS CONTRA INFECCIONES CAUSADAS POR PSEUDOMONAS AERUGINOSA

PRE2021-097678

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluating Host Defense Peptides, A Comparative Analysis of Synthetic Peptides and Recombinant Concatemers

  • Saubi, Cristina|||0000-0002-1866-8418
  • Carratalá, José Vicente|||0000-0001-6950-2939
  • Bello Madruga, Roberto|||0009-0003-8474-3951
  • López-Cano, Adrià
  • Navarro, Susanna|||0000-0001-8160-9536
  • Arís i Giralt, Anna|||0000-0001-7830-888X
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
The global antibiotic resistance crisis raises concerns about antibiotic use, and alternative strategies are urgently needed. In this context, host defense peptides (HDPs) have rapidly gained interest. However, one of the main obstacles is their production strategy. Chemical synthesis is the most widely used, although it is not scalable and has sequence limitations. A possible alternative is recombinant production, but the strategies used so far have limited efficiency. In this study, we aim to compare the activity and main characteristics of different HDPs produced by both chemical synthesis and by recombinant production, using an approach based on tetramers to ameliorate the production process. The results obtained showed that the production of HDPs as tetrameric peptides by recombinant production in Lactococcus lactis enhanced the peptide activity, with HDPs being much more active in terms of antimicrobial activity, more structurally stable, and nanostructured. Thus, the recombinant strategy described herein, fusing four repetitions of the same peptide, can become a real alternative to produce highly active HDPs through a scalable production process.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria

  • Bello-Madruga, Roberto
  • Sandín, Daniel
  • Valle, Javier
  • Gómez, Jordi
  • Comas, Laura
  • Larrosa, María Nieves
  • González-López, Juan José
  • Jiménez, M. Angeles
  • Andreu, David
  • Torrent, Marc
Glycosaminoglycan (GAG)-binding proteins regulating essential processes such as cell growth and migration are essential for cell homeostasis. As both GAGs and the lipid A disaccharide core of Gram-negative bacteria contain negatively charged disaccharide units, we hypothesized that GAG-binding proteins could also recognize LPS and enclose cryptic antibiotic motifs. Here, we report novel antimicrobial peptides (AMPs) derived from heparin-binding proteins (HBPs), with specific activity against Gram-negative bacteria and high LPS binding. We used computational tools to locate antimicrobial regions in 82% of HBPs, most of those colocalizing with putative heparin-binding sites. To validate these results, we synthesized five candidates [HBP-1-5] that showed remarkable activity against Gram-negative bacteria, as well as a strong correlation between heparin and LPS binding. Structural characterization of these AMPs shows that heparin or LPS recognition promotes a conformational arrangement that favors binding. Among all analogs, HBP-5 displayed the highest affinity for both heparin and LPS, with antimicrobial activities against Gram-negative bacteria at the nanomolar range. These results suggest that GAG-binding proteins are involved in LPS recognition, which allows them to act also as antimicrobial proteins. Some of the peptides reported here, particularly HBP-5, constitute a new class of AMPs with specific activity against Gram-negative bacteria., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/ PRTR to MT; project PID2020-114627RB-I00 funded by MCIN/AEI/10.13039/501100011033 to MT; PID2020-112821GB-I00 funded by MCIN/AEI/10.13039/501100011033 to MAJ and PID2020-113184RB-C22 to DA), the Departament de Recerca iUniversitats de la Generalitat de Catalunya (2023PROD00021 to MT), and from La Caixa Banking Foundation (HR17-00409, to DA). This work has been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union Next Generation EU, from the Recovery, Transformationand Resilience Plan (PRTR-C17.I1), European Society of Clinical Microbiologyand Infectious Diseases (ESCMID) ESCMID2022 and from the Autonomous Community of Catalonia within the framework of the Biotechnology PlanApplied to Health. Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. NMR experiments were performed in the“Manuel Rico” NMR laboratory (LMR) of the Spanish National ResearchCouncil (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). DS and RBM are recipients of pre-doctoral a FPI scholarship (PRE2018-083243 and PRE2021-097678, respectively) from the Spanish Ministry ofScience and Innovation, Peer reviewed